Free Trial

Turnstone Biologics (TSBX) Earnings Date, Estimates & Call Transcripts

Turnstone Biologics logo
$0.45 -0.05 (-10.36%)
(As of 05:27 PM ET)

Turnstone Biologics Latest Earnings Summary

Actual EPS
(Nov. 12)
-$0.74 Beat By $0.13
Consensus EPS
(Nov. 12)
-$0.87

Turnstone Biologics issued Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.74, which beat analysts' consensus estimates of -$0.87 by $0.13. With a trailing EPS of -$3.24, Turnstone Biologics' earnings are expected to grow next year, from ($3.75) to ($2.50) per share.

Get Turnstone Biologics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Turnstone Biologics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

TSBX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TSBX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Turnstone Biologics Analyst EPS Estimates

Current Year EPS Consensus Estimate:($3.75) EPS
Next Year EPS Consensus Estimate: ($2.50) EPS

Turnstone Biologics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/12/2024--$0.87-$0.74+$0.13-$0.74--
8/14/2024--$0.84-$0.92 -$0.08-$0.92--
5/13/2024Q1 2024-$0.78-$0.85 -$0.07-$0.85--
3/21/2024Q4 2023-$0.86-$0.73+$0.13-$0.73--
11/9/2023Q3 2023-$0.67-$1.00 -$0.33-$1.00--
9/1/2023Q2 2023-$3.01-$7.56 -$4.55-$7.56--

Turnstone Biologics Earnings - Frequently Asked Questions

Turnstone Biologics (NASDAQ:TSBX) last announced its quarterly earning data on Tuesday, November 12, 2024. Learn more on TSBX's earnings history.

In the previous quarter, Turnstone Biologics (NASDAQ:TSBX) reported ($0.74) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.87) by $0.13. Learn more on analysts' earnings estimate vs. TSBX's actual earnings.

Turnstone Biologics (NASDAQ:TSBX) has a recorded annual revenue of $19.31 million.

Turnstone Biologics (NASDAQ:TSBX) has a recorded net income of -$55.20 million. TSBX has generated -$3.24 earnings per share over the last four quarters.

Turnstone Biologics's earnings are expected to grow from ($3.75) per share to ($2.50) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:TSBX) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners